Clinical Trials Logo

Clinical Trial Summary

The investigators are doing this study to compare blood levels and side effects of cariprazine when it's taken as one of two 'slow release' tablets, or as an 'immediate release' capsule. The investigators will also find out if food affects the absorption of cariprazine into the bloodstream after a 'slow release' tablet.


Clinical Trial Description

Comparison of blood levels and side effects of cariprazine when it's taken as one of two 'slow release' tablets, or as an 'immediate release' capsule. We'll also find out if food affects the absorption of cariprazine into the bloodstream after a 'slow release' tablet. ;


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02165098
Study type Interventional
Source Gedeon Richter Plc.
Contact
Status Completed
Phase Phase 1
Start date June 2014
Completion date February 2016

See also
  Status Clinical Trial Phase
Completed NCT02025348 - Explore the Performance of IntelliCap. Phase 0